GlaxoSmithKline SWOT Analysis

By John Dudovskiy
February 5, 2013

GlaxoSmithKline SWOT AnalysisSWOT stands for strengths, weaknesses, opportunities, and threats associated with a business and it is an effective strategic analytical tool used to assess businesses.  The following table illustrates GlaxoSmithKline SWOT Analysis :

Strengths

  • Increased level of R&D potential
  • Strong financial position
  • Global coverage with presence in more than 100 countries
 Weaknesses

  • Considerable damage made to brand image because of Avandia drug scandal
  • Ineffective online presence
  • Low level of flexibility due to the large size of the company
Opportunities

  • Increasing the level of presence in China and India
  • Following diversification strategy
  • Improving the level of online presence
 Threats

  • Lawsuits to damage the brand image
  • New competitors joining the market
  • Worsening of economic situation in Europe

 

Category: SWOT Analyses
[]